Phase II study of etoposide for carcinoma of the bladder: the Southeastern Cancer Study Group experience.
D004341:Drug Evaluation; D005047:Etoposide / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology
D005047:Etoposide